- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 589048, 9 pages
Different Mechanisms of Inflammation Induced in Virus and Autoimmune-Mediated Models of Multiple Sclerosis in C57BL6 Mice
1Department of Biological Sciences, Indian Institute of Science Education and Research-Kolkata,
Mohanpur, Nadia West Bengal 741252, India
2IISER Mohali, Knowledge City, Sector 81, SAS Nagar, Mohali 140306, India
3Department of Neurology, Thomas Jefferson University, Philadelphia, PA 19107, USA
4Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia PA 19107, USA
5University of Pennsylvania, Scheie Eye Institute and F.M. Kirby Center for Molecular Ophthalmology, Philadelphia, PA 19104, USA
Received 7 April 2013; Accepted 1 July 2013
Academic Editor: Arianna Scuteri
Copyright © 2013 Abhinoy Kishore et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker, “Multiple sclerosis,” The New England Journal of Medicine, vol. 343, no. 13, pp. 938–952, 2000.
- R. Martin, H. F. McFarland, and D. E. McFarlin, “Immunological aspects of demyelinating diseases,” Annual Review of Immunology, vol. 10, pp. 153–187, 1992.
- M. Sospedra and R. Martin, “Immunology of multiple sclerosis,” Annual Review of Immunology, vol. 23, pp. 683–747, 2005.
- S. Sawcer, H. B. Jones, R. Feakes et al., “A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22,” Nature Genetics, vol. 13, no. 4, pp. 464–468, 1996.
- G. C. Ebers, “Genetic epidemiology of multiple sclerosis,” Current Opinion in Neurology, vol. 9, no. 3, pp. 155–158, 1996.
- G. C. Ebers, K. Kukay, D. E. Bulman et al., “A full genome search in multiple sclerosis,” Nature Genetics, vol. 13, no. 4, pp. 472–476, 1996.
- J. L. Haines, M. Ter-Minassian, A. Bazyk et al., “A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex,” Nature Genetics, vol. 13, no. 4, pp. 469–471, 1996.
- Q. Ji, A. Perchellet, and J. M. Goverman, “Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs,” Nature Immunology, vol. 11, no. 7, pp. 628–634, 2010.
- E. S. Huseby, D. Liggitt, T. Brabb, B. Schnabel, C. Öhlén, and J. Goverman, “A pathogenic role for myelin-specific CD8+ T cells in a model for multiple sclerosis,” Journal of Experimental Medicine, vol. 194, no. 5, pp. 669–676, 2001.
- T. Tsuchida, K. C. Parker, R. V. Turner, H. F. McFarland, J. E. Coligan, and W. E. Biddison, “Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 23, pp. 10859–10863, 1994.
- D. H. Gilden, “Infectious causes of multiple sclerosis,” Lancet Neurology, vol. 4, no. 3, pp. 195–202, 2005.
- S. D. Cook and P. C. Dowling, “Multiple sclerosis and viruses: an overview,” Neurology, vol. 30, no. 7, part 2, pp. 80–91, 1980.
- J. F. Kurtzke, “Epidemiologic evidence for multiple sclerosis as an infection,” Clinical Microbiology Reviews, vol. 6, no. 4, pp. 382–427, 1993.
- C. Cermelli and S. Jacobson, “Viruses and multiple sclerosis,” Viral Immunology, vol. 13, no. 3, pp. 255–267, 2000.
- S. Kuerten, T. L. Gruppe, L.-M. Laurentius et al., “Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35–55, and PLP peptide 178–191 in C57BL/6 mice,” APMIS, vol. 119, no. 6, pp. 336–346, 2011.
- M. C. Dal Canto, B. S. Kim, S. D. Miller, and R. W. Melvold, “Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination: a model for human multiple sclerosis,” Methods, vol. 10, no. 3, pp. 453–461, 1996.
- E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas, “Theiler's virus infection: a model for multiple sclerosis,” Clinical Microbiology Reviews, vol. 17, no. 1, pp. 174–207, 2004.
- J. J. Houtman and J. O. Fleming, “Pathogenesis of mouse hepatitis virus-induced demyelination,” Journal of NeuroVirology, vol. 2, no. 6, pp. 361–376, 1996.
- E. Lavi, D. H. Gilden, and Z. Wroblewska, “Experimental demyelination produced by the A59 strain of mouse hepatitis virus,” Neurology, vol. 34, no. 5, pp. 597–603, 1984.
- S. A. Stohlman and L. P. Weiner, “Chronic central nervous system demyelination in mice after JHM virus infection,” Neurology, vol. 31, no. 1, pp. 38–44, 1981.
- L. P. Weiner, “Pathogenesis of demyelination induced by a mouse hepatitis,” Archives of Neurology, vol. 28, no. 5, pp. 298–303, 1973.
- E. Lavi, D. H. Gilden, M. K. Highkin, and S. R. Weiss, “Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization,” Journal of Virology, vol. 51, no. 2, pp. 563–566, 1984.
- S. Perlman, G. Jacobson, A. L. Olson, and A. Afifi, “Identification of the spinal cord as a major site of persistence during chronic infection with a murine coronavirus,” Virology, vol. 175, no. 2, pp. 418–426, 1990.
- J. L. Gombold and S. R. Weiss, “Mouse Hepatitis Virus A59 increases steady-state levels of MHC mRNAs in primary glial cell cultures and in the murine Central Nervous System,” Microbial Pathogenesis, vol. 13, no. 6, pp. 493–505, 1992.
- E. Lavi, A. Suzumura, L. A. Lampson et al., “Expression of MHC class I genes in mouse hepatitis virus (MHV-A59) infection and in multiple sclerosis,” Advances in Experimental Medicine and Biology, vol. 218, pp. 219–222, 1987.
- E. Lavi, A. Suzumura, E. M. Murray, D. H. Silberberg, and S. R. Weiss, “Induction of MHC class I antigens on glial cells is dependent on persistent mouse hepatitis virus infection,” Journal of Neuroimmunology, vol. 22, no. 2, pp. 107–111, 1989.
- A. Suzumura, E. Lavi, S. R. Weiss, and D. H. Silberberg, “Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes,” Science, vol. 232, no. 4753, pp. 991–993, 1986.
- A. Suzumura, E. Lavi, S. Bhat, D. Murasko, S. R. Weiss, and D. H. Silberberg, “Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells,” Journal of Immunology, vol. 140, no. 6, pp. 2068–2072, 1988.
- A. E. Matthews, E. Lavi, S. R. Weiss, and Y. Paterson, “Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59,” Journal of NeuroVirology, vol. 8, no. 3, pp. 257–264, 2002.
- R. M. Sutherland, M.-M. Chua, E. Lavi, S. R. Weiss, and Y. Paterson, “CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease,” Journal of NeuroVirology, vol. 3, no. 3, pp. 225–228, 1997.
- J. Das Sarma, L. C. Kenyon, S. T. Hingley, and K. S. Shindler, “Mechanisms of primary axonal damage in a viral model of multiple sclerosis,” Journal of Neuroscience, vol. 29, no. 33, pp. 10272–10280, 2009.
- J. Das Sarma, B. Ciric, R. Marek et al., “Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis,” Journal of Neuroinflammation, vol. 6, article 14, 2009.
- D. C. Fitzgerald, B. Ciric, T. Touil et al., “Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis,” Journal of Immunology, vol. 179, no. 5, pp. 3268–3275, 2007.
- J. Das Sarma, K. Iacono, L. Gard et al., “Demyelinating and nondemyelinating strains of mouse hepatitis virus differ in their neural cell tropism,” Journal of Virology, vol. 82, no. 11, pp. 5519–5526, 2008.
- K. S. Shindler, L. C. Kenyon, M. Dutt, S. T. Hingley, and J. Das Sarma, “Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus,” Journal of Virology, vol. 82, no. 17, pp. 8882–8886, 2008.
- J. Das Sarma, E. Scheen, S.-H. Seo, M. Koval, and S. R. Weiss, “Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system,” Journal of NeuroVirology, vol. 8, no. 5, pp. 381–391, 2002.
- L. J. Reed and H. Muench, “A simple method of estimating fifty per cent endpoints,” American Journal of Epidemiology, vol. 27, no. 3, pp. 493–497, 1938.
- J. D. Sarma, L. Fu, S. T. Hingley, and E. Lavi, “Mouse hepatitis virus type-2 infection in mice: an experimental model system of acute meningitis and hepatitis,” Experimental and Molecular Pathology, vol. 71, no. 1, pp. 1–12, 2001.
- J. Das Sarma, L. Fu, J. C. Tsai, S. R. Weiss, and E. Lavi, “Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus,” Journal of Virology, vol. 74, no. 19, pp. 9206–9213, 2000.
- J. J. Phillips, M. M. Chua, G. F. Rall, and S. R. Weiss, “Murine coronavirus spike glycoprotein mediates degree of viral spread, inflammation, and virus-induced immunopathology in the central nervous system,” Virology, vol. 301, no. 1, pp. 109–120, 2002.
- S. Navas, S.-H. Seo, M. M. Chua et al., “Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis,” Journal of Virology, vol. 75, no. 5, pp. 2452–2457, 2001.